, Tracking Stock Market Picks
Enter Symbol:
Delcath Systems, Inc. (DCTH) [hlAlert]

up 43,529.26 %

Delcath Systems, Inc. (DCTH) rated Sell by BioLogic Equity Research

Posted on: Tuesday,  Jun 8, 2010  10:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell Delcath Systems, Inc. (NASDAQ: DCTH) on 06/08/2010, when the stock price was $178.88.
Since then, Delcath Systems, Inc. has lost 99.77% as of 01/25/2016's recent price of $0.41.
If you would have followed this BioLogic Equity Research's recommendation on DCTH, you would have gained 43529.3% of your investment in 2057 days.

Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/8/2010 10:25 AM Sell
as of 12/31/2010
1 Week up  11.29 %
1 Month up  11.03 %
3 Months down  -24.30 %
1 YTD up  19.94 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy